samedan logo
 
 
spacer
home > ict > Summer 2012
PUBLICATIONS

International Clinical Trials

ict
Summer 2012
   
Text
PDF
bullet
Regulatory & Business Practice
Prescription Drug User Fee Act

Navigating the Initiatives

Nina Baluja, George R Hemsworth, Mehri Hezari-Adam, Pat Mann and Henrietta Ukwu at PPD explain how the changes in the Prescription Drug User Fee Act will affect pharmaceutical and biotechnology companies in terms of cost and timeframes.
 
view
download pdf


Clinical Research Training

Raising the Bar

Precise training strategies help to ensure that clinical research professionals are equipped to perform well in the workplace, explains Martin Robinson at the International Academy of Clinical Research.

 
view
download pdf
bullet
PREVIEW

Partnerships in Clinical Trials Europe

Adapting to Change

Learn about strategic and practical approaches to enhancing relationships between trial sponsors and their suppliers at this upcoming event in November.
 
view
download pdf

Industry Interview: Lotus Labs

The Road to Madrid

Dr Yati Chugh talks to ICT about the clinical research scene in India, and what he is looking forward to at ICSE.
 
view
download pdf

Showcase: ICSE

Event Preview Ready for Business?

Get ready to network and learn at the ICSE event in Feria de Madrid, taking place in October.
 
view
download pdf
Editorís Comment

Graham Hughes notes how the clinical trials world is increasingly patient-centric in its approach.
 
view
download pdf
bullet
Regional trials
Regional Trials: India

Shining Light

Apurva Shah at Veeda Clinical Research and Ashish Kumar Dasgupta of the Association of Contract Research Organizations discuss how revisions to regulatory processes in India are transforming the appeal of conducting clinical trials in the subcontinent.
 
view
download pdf

Regional Trials: China

Betting Big

As China becomes an increasingly important player in the pharma industry, Nick Stephens of RSA speculates on the changes that will occur in terms of R&D.
 
view
download pdf
eCLINICAL, DATA MANAGEMENT & STATISTICAL ANALYSIS
Patient-Centric Trials

Drug Development 2.0

Tomasz Sablinski of Transparency Life Sciences investigates new trial design elements that are shaping the future of drug development, including crowdsourcing, data transparency and telemedicine.
 
view
download pdf

Mobile Technology

Capturing the Patientís Voice

Judith Teall at Exco InTouch explains how mobile technology is driving a more patient-centric approach to late phase research.
 
view
download pdf

Measurement-Based Care

The Patient as an Individual

Stephen Webb at REGISTRAT-MAPI North America shares his thoughts on the developments that are occurring in the healthcare industry and examines whether measurement-based care can improve outcomes for patients and reduce costs.
 
view
download pdf
Serious Adverse Events Reporting

Safely Does It

Knowledge regarding serious adverse events is crucial in the process of clinical development. Rick Morrison at Comprehend Systems describes how new data visualisation and statistical analysis software can improve the accuracy of reporting
 
view
download pdf

Monitoring Data Management

Doing More with Less

Richard Young at Medidata Solutions delves into risk-based monitoring Ė an area that is being changed and modernised through a series of new technological breakthroughs.
 
view
download pdf
Statistical Analysis

Non-Response: Issue or Inconvenience?

Missing data may pose a problem for those carrying out clinical trials, but as Andrew Grannell at Statistical Solutions explains, non-response may actually be able to contribute additional information to studies.
 
view
download pdf
bullet
Labs & Logistics

Logistics: South America

Right Place, Right Time

Angus Macleod at Catalent Pharma Solutions assesses the importance of taking the differences in regional regulations into account when importing clinical trial materials.
 
view
download pdf

Partnering with Central Labs, ECG and Imaging Labs


Outsourcing Strategies

Graham Hughes reports from
Partnering with Central Labs, ECG and Imaging Labs Ė an Informa Life Sciences Conference held in Brussels.
 
view
download pdf

Global Sample Management Benchmarking Symposium

Strategic Sample Management

Graham Hughes provides a round-up from an information-packed symposium that was organised by Biostorage Technologies, and sponsored by ICT.



 
view
download pdf
bullet
Reviews
Graham Hughes reviews Principles and Practice of Clinical Research: Third Edition, edited by John I Gallin and Frederick P Ognibene.
 
view
download pdf

Patient Recruitment and Retention
Study Recruitment: Social Media Feasibility Model

Status Update

The trend for using social media platforms to recruit patients for clinical trials is on the rise. Before embarking on this approach, Rahlyn Gossen at Rebar Interactive outlines the importance of a feasibility model, based on an assessment of the patient, the organisationís ability, and the budget available
 
view
download pdf
Patient Engagement

Bring it Online

Finding ways to actively engage the patient in a clinical trial has proved to be far from straightforward exercise. Aaron B Fleishman at BBK Worldwide shows how social media tools can be employed to raise awareness of the science behind the clinical research.
 
view
download pdf

Interview
Industry Interview: Thinking Allowed

Maria V Lopez-Bresnahan of PharmaNet/i3 talks to ICT about her clinical trials experience, and what the future holds for the industry.

 
view
download pdf
   
spacer
Edited by
Dr Graham Hughes
Consultant in
Pharmaceutical
Development

Published quarterly in
February, May,
August, and November

News and Press Releases

Clinical and Regulatory Operational Excellence Forum

1. Innovative technologies are expected to take clinical development, licensing, and other regulatory processes to the next level in the future. What do you see are the biggest challenges facing companies when trying to cope with continued data growth in a fast changing environment? Pharmaceutical companies are heavily regulated and introducing change needs proof of acceptance by the authorities. The chance that authorities do not agree with that change makes the industry risk averse. Changes in a stable GxP environment are almost by default seen as a risk, however, not adapting to new technologies should also be seen as a risk! Therefore, ICH developed the ICH Q8, Q9, Q10, Q11, and Q12 guidelines, to anticipate change and implement changes much faster, with less of a regulatory burden. Nevertheless, industry is not picking up with the desired pace. Why not?
More info >>

White Papers

Driving ROI: The Case for Investing in Contract & Site Regulatory Document Management Services

DrugDev

With tight timelines and complicated regulatory documentation requirements, getting a clinical trial up and running quickly is easier said than done. Key milestones can be achieved only after the successful negotiation of clinical trial agreements and completion of essential regulatory documents. Many clinical trials are hindered by inefficient, labor-intensive processes. Prolonged, inefficient activation can hamper investigator satisfaction and, ultimately, have a negative bottom-line impact for sponsors and CROs. In addition, the Sunshine Act is heightening the importance of financial disclosure in clinical trials. Without a robust financial disclosure strategy, sponsors cannot ensure that physician self-reported financial disclosure data are aligned with the payment data being reported through the Sunshine Act, increasing financial and regulatory risk.
More info >>

Industry Events

Pre-Filled Syringes & Injectable Drug Devices Europe

16-17 January 2019, Copthorne Tara Hotel, London

SMi is proud to present their 11th annual European conference and exhibition, within the Pre-Filled Syringes series: Pre-Filled Syringes & Injectable Drug Devices Europe. The event will take place on the 16th-17th of January 2019, in London.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement